1
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
2
|
Srinivasula SM and Ashwell JD: IAPs:
What's in a name? Mol Cell. 30:123–135. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Storlazzi CT, Brekke HR, Mandahl N, et al:
Identification of a novel amplicon at distal 17q containing the
BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours. J
Pathol. 209:492–500. 2006. View Article : Google Scholar : PubMed/NCBI
|
4
|
Connell CM, Colnaghi R and Wheatley SP:
Nuclear survivin has reduced stability and is not cytoprotective. J
Biol Chem. 283:3289–3296. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Salvesen GS and Duckett CS: IAP proteins:
Blocking the road to death's door. Nat Rev Mol Cell Biol.
3:401–410. 2002. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Stauber RH, Mann W and Knauer SK: Nuclear
and cytoplasmic survivin: Molecular mechanism, prognostic, and
therapeutic potential. Cancer Res. 67:5999–6002. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Knauer SK, Mann W and Stauber RH:
Survivin's dual role: An export's view. Cell Cycle. 6:518–521.
2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Mull AN, Klar A and Navara CS:
Differential localization and high expression of SURVIVIN splice
variants in human embryonic stem cells but not in differentiated
cells implicate a role for SURVIVIN in pluripotency. Stem Cell Res
(Amst). 12:539–549. 2014. View Article : Google Scholar
|
9
|
Li F and Ling X: Survivin study: An update
of ‘What is the next wave’? J Cell Physiol. 208:476–486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Hernandez JM, Farma JM, Coppola D, et al:
Expression of the antiapoptotic protein survivin in colon cancer.
Clin Colorectal Cancer. 10:188–193. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Xie YL, An L, Jiang H and Wang J: Nuclear
survivin expression is associated with a poor prognosis in
Caucasian non-small cell lung cancer patients. Clin Chim Acta.
414:41–43. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Vivas-Mejia PE, Rodriguez-Aguayo C, Han
HD, et al: Silencing survivin splice variant 2B leads to antitumor
activity in taxane-resistant ovarian cancer. Clin Cancer Res.
17:3716–3726. 2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Morinaga S, Nakamura Y, Ishiwa N, et al:
Expression of survivin mRNA associates with apoptosis,
proliferation and histologically aggressive features in
hepatocellular carcinoma. Oncol Rep. 12:1189–1194. 2004.PubMed/NCBI
|
14
|
Zhu H, Wang Q, Hu C, et al: High
expression of survivin predicts poor prognosis in esophageal
squamous cell carcinoma following radiotherapy. Tumour Biol.
32:1147–1153. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Sun YW, Xuan Q, Shu QA, et al: Correlation
of tumor relapse and elevated expression of survivin and vascular
endothelial growth factor in superficial bladder transitional cell
carcinoma. Genet Mol Res. 12:1045–1053. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Vallböhmer D, Drebber U, Schneider PM, et
al: Survivin expression in gastric cancer: Association with
histomorphological response to neoadjuvant therapy and prognosis. J
Surg Oncol. 99:409–413. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ichiki Y, Hanagiri T, Takenoyama M, et al:
Tumor specific expression of survivin-2B in lung cancer as a novel
target of immunotherapy. Lung Cancer. 48:281–289. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hirano H, Maeda H, Takeuchi Y, et al:
Association of cigarette smoking with the expression of nuclear
survivin in pathological Stage IA lung adenocarcinomas. Med Mol
Morphol. 47:196–200. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gerdes J, Schwab U, Lemke H and Stein H:
Production of a mouse monoclonal antibody reactive with a nuclear
antigen associated with cell proliferation. Int J Cancer. 31:13–20.
1983. View Article : Google Scholar : PubMed/NCBI
|
20
|
Nguyen VN, Mirejovský P, Mirejovský T, et
al: Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung
cancer: Prognostic significance and comparison with p53 and bcl-2.
Acta Histochem. 102:323–338. 2000. View Article : Google Scholar : PubMed/NCBI
|
21
|
Maeshima AM, Tochigi N, Tsuta K, et al:
Histological evaluation of the effect of smoking on peripheral
small adenocarcinomas of the lung. J Thorac Oncol. 3:698–703. 2008.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Dasgupta P, Kinkade R, Joshi B, et al:
Nicotine inhibits apoptosis induced by chemotherapeutic drugs by
up-regulating XIAP and survivin. Proc Natl Acad Sci USA.
103:6332–6337. 2006. View Article : Google Scholar : PubMed/NCBI
|
23
|
Maeda R, Yoshida J, Ishii G, et al:
Influence of cigarette smoking on survival and tumor invasiveness
in clinical stage IA lung adenocarcinoma. Ann Thorac Surg.
93:1626–1632. 2012. View Article : Google Scholar : PubMed/NCBI
|